Services
Data Cards
Blogs
Resources
Contact Us
Get 50 Free SamplesContact Us

Infectious Disease Email List | 18,420 Verified Contacts | SparkDBi

Infectious Disease as a Consulting Specialty

Infectious disease physicians occupy a unique position in hospital medicine: they function primarily as consultants rather than primary prescribers. When a patient develops a drug-resistant infection, an opportunistic infection in an immunocompromised host, or a febrile illness that defies initial diagnosis, the treating team calls for an ID consultation. The ID physician then drives the antimicrobial selection, dose, and duration, recommends diagnostic testing, and monitors outcomes. This consulting role makes ID physicians the most influential specialist group for antimicrobial prescribing decisions in inpatient medicine, even though the primary team holds the actual prescribing order.

In outpatient HIV care and sexually transmitted infection management, ID physicians function as primary prescribers. HIV clinics at academic medical centres, federally qualified health centres, and Ryan White-funded programmes are staffed primarily by ID physicians with HIV Medicine subspecialty expertise. In travel medicine clinics and occupational health settings, ID physicians manage pre-travel vaccination, prophylaxis, and post-travel illness evaluation. These ambulatory settings require different outreach strategies from inpatient hospital-based ID consultation programs.

Request Infectious Disease Contact Data

Subspecialty filters, practice setting, sample records available


An infectious disease email list is a verified database of licensed infectious disease physicians, HIV specialists, travel medicine physicians, ID nurse practitioners, and ID physician assistants, built from conference and CME partnerships, state and national professional association directories, healthcare publication networks, and B2B2C matching and verification programs. SparkDBi maintains 18,420 verified US infectious disease contacts across 8 subspecialties.

SparkDBi Data Research Team Updated June 2026 10 min read
18,420Verified Contacts
8Subspecialties
90.8%Email Verified
MonthlyRefresh Cycle

Trusted by 2,600+ world-class brands and organizations

Eli LillyNTT DATAOracleSurveyMonkeyThermo Fisher ScientificWPPAmerican Express

SparkDBi maintains a verified infectious disease email list covering 18,420 ID physicians, HIV specialists, travel medicine physicians, transplant ID physicians, ID nurse practitioners, and ID physician assistants across the United States. Every contact is sourced from conference and CME partnerships, state licensing records, and professional association directories, then validated through email inbox verification, phone validation, and physical address confirmation. The database refreshes monthly.


Clinical Scope: Drugs and Diagnostics in Infectious Disease

Hospital-acquired and drug-resistant infections represent the highest-value prescribing category for ID physicians. Beta-lactam/beta-lactamase inhibitor combinations (ceftazidime-avibactam, ceftolozane-tazobactam, imipenem-cilastatin-relebactam, aztreonam-avibactam) address carbapenem-resistant gram-negative organisms. Cefiderocol, a siderophore cephalosporin, covers pan-resistant Acinetobacter and other extreme-resistant gram-negatives. For gram-positive organisms including MRSA and vancomycin-resistant enterococcus, daptomycin, linezolid, tedizolid, dalbavancin, and oritavancin are the key agents requiring ID physician guidance.

Antifungal programs require ID or infectious disease specialist outreach. Voriconazole, isavuconazole, and posaconazole are the primary triazoles for mould infections. Micafungin, caspofungin, and anidulafungin cover invasive Candida. Liposomal amphotericin B (AmBisome) addresses severe or refractory fungal disease. Olorofim (Synclara), a first-in-class dihydroorotate dehydrogenase inhibitor, represents the newest approved antifungal for invasive aspergillosis in patients who fail or cannot tolerate standard therapy.

HIV antiretroviral therapy is the defining outpatient prescribing area for HIV-focused ID physicians. Single-tablet regimens including bictegravir/tenofovir alafenamide/emtricitabine (Biktarvy) dominate initial treatment. Long-acting injectable ART (cabotegravir/rilpivirine, lenacapavir) represents the fastest-growing segment, requiring ID physician outreach for treatment-experienced and adherence-challenged patients. Lenacapavir (Sunlenca) also has a unique injectable preventive indication, expanding its prescriber target beyond treatment-focused ID physicians.

Respiratory virus antivirals require ID physician outreach for high-risk patient programs. Nirmatrelvir/ritonavir (Paxlovid) for COVID-19, oseltamivir and baloxavir for influenza, nirsevimab (Beyfortus) and palivizumab for RSV prophylaxis in high-risk infants, and ribavirin-based regimens for specific viral haemorrhagic fevers all involve ID physician consultation or prescribing authority in complex patients.


Antimicrobial Stewardship: A Unique ID Outreach Category

Antimicrobial stewardship programs (ASPs) are led by ID physicians and ID-trained clinical pharmacists at virtually every accredited US hospital. The Joint Commission and CMS both require antimicrobial stewardship programs as a condition of accreditation and participation. The ASP lead is typically an ID physician who sets institutional prescribing policies, reviews high-cost and restricted antibiotic use, and approves or denies requests for restricted antimicrobials through prior authorization programs.

For pharmaceutical companies launching new antibiotics, antifungals, or antivirals into the hospital market, the ID physician ASP lead is a critical gatekeeper. Formulary addition, restriction classification, and clinical pathway inclusion decisions all go through or involve the ASP physician. Reaching ID physicians in ASP leadership roles requires practice-type filtering to identify hospital-based ID physicians with academic or administrative titles, as distinct from outpatient HIV clinic or travel medicine ID physicians.

SparkDBi can filter the ID physician database by practice setting to identify hospital-based ID physicians most likely to hold ASP leadership or committee roles, as distinct from outpatient or travel medicine practices. This segmentation is particularly valuable for companies with restricted antibiotic products entering hospital formulary review cycles.


Who Uses the Infectious Disease Email List

Pharmaceutical companies with novel antibiotics, antifungals, and hospital antivirals represent the core buyer. The hospital anti-infective market requires ID physician access across both ASP committee influencers and frontline clinical prescribers in ICU, haematology-oncology, solid organ transplant, and immunosuppressed patient care settings.

HIV pharmaceutical companies use the ID list for outreach to HIV-focused ID physicians managing switch programs from older regimens to newer single-tablet and long-acting injectable ART options. Diagnostic companies with rapid susceptibility testing platforms, multiplex respiratory PCR panels, and blood culture identification systems use the ID list for laboratory director and ID physician champion outreach programs.

BuyerHow They Use the Infectious Disease List
Pharma - novel antibioticID physician outreach for hospital-acquired and drug-resistant gram-negative infection programs, filtered for hospital-based ID physicians with ASP roles
Pharma - HIV ARTHIV-focused ID physician list for long-acting injectable ART switch programs in treatment-experienced patients, filtered by HIV clinic setting
Pharma - antifungalID physician and haematology-oncology ID specialist outreach for invasive fungal infection programs in immunocompromised patient settings
Diagnostics - rapid IDID physician and microbiology lab director outreach for rapid susceptibility testing platform adoption in academic and community hospital settings
CME - antimicrobial stewardshipID physician outreach for antimicrobial stewardship CME program faculty recruitment and participant enrollment

Infectious Disease Subspecialties and Verified Contacts

The SparkDBi infectious disease database covers 8 subspecialty segments. All segments are available individually or in combination with subspecialty flags.

SubspecialtyProvider TypeContacts
Infectious Disease PhysicianPhysician11,200
ID Nurse PractitionerNurse Practitioner2,100
ID Physician AssistantPhysician Assistant1,500
HIV Medicine SpecialistPhysician1,200
Travel Medicine PhysicianPhysician800
Tropical Medicine and ParasitologyPhysician620
Transplant Infectious DiseasePhysician600
Pediatric Infectious DiseasePhysician400

All 8 subspecialty segments by verified contact count. Total: 18,420.


Geographic Coverage

The US infectious disease database covers all 50 states. Highest concentrations are in California, New York, Texas, and Florida, reflecting population density and the locations of major academic infectious disease programs, HIV care networks, and large hospital systems with ID consultation services.

Top 10 US States - Verified Infectious Disease Contacts
StateVerified Contacts
California2,650
New York2,180
Texas1,740
Florida1,520
Pennsylvania1,080
Massachusetts920
Illinois840
Ohio730
Maryland680
Washington590

International infectious disease data is available for the UK, Germany, France, Canada, and Australia. Contact SparkDBi for current counts by country.


How SparkDBi Sources and Verifies HCP Data

SparkDBi builds its HCP contact database from multiple vetted channels. Primary sources include conference attendance and CME event participation records from healthcare education partners, member directories from state and national professional associations, subscriber and contributor lists from healthcare publication networks, and B2B2C data matching and verification partnerships.

Publicly available sources including CMS and NPPES records are used as a cross-reference and comparison tool only. CMS and NPPES data is frequently stale or out of date for direct contact purposes. SparkDBi treats it as one reference point among many rather than a source of record.

Verification runs across three dimensions. Email inbox verification connects directly to the receiving mail server and confirms the specific mailbox accepts incoming messages, without sending a message. Phone validation confirms work phone numbers are active and matched to the provider record. Physical address validation covers both work practice addresses and home addresses, with records that fail validation removed and replaced in the next monthly refresh cycle.


NPI Taxonomy Codes for Infectious Disease

CMS NPI taxonomy codes for reference. These are useful when specifying subspecialty requirements or independently verifying provider credentials.

Taxonomy CodeClassification
207RI0200XInfectious Disease
2080I0007XPediatrics - Infectious Disease
207RI0001XClinical and Laboratory Immunology
363L00000XNurse Practitioner (ID setting)
363A00000XPhysician Assistant (ID setting)

Practice Setting Breakdown

Infectious disease physicians are predominantly hospital-based consultants or academic medical centre faculty. Approximately 65% of ID physicians in the SparkDBi database practice in hospital-employed, academic, or VA/federal settings. The remaining 35% practice in outpatient HIV clinics, travel medicine clinics, private ID practices, or multi-specialty group settings.

Hospital-based ID physicians are the most important segment for antibiotic, antifungal, and hospital antiviral outreach. Outpatient HIV clinic ID physicians are the most important segment for antiretroviral therapy program outreach. SparkDBi can filter by practice setting to target the right ID physician population for each campaign type.


Deliverability

Most infectious disease physicians use academic health system or hospital enterprise email, which applies aggressive spam filtering. Outpatient HIV clinic and travel medicine ID physicians in private or FQHC settings tend to use practice-domain email with better inbox placement. SparkDBi flags enterprise vs independent email domains in delivered datasets for send strategy planning.


Data Enrichment and Available Fields

For existing infectious disease contact lists, SparkDBi can append or verify: NPI numbers, subspecialty classifications, practice setting, email addresses, practice addresses, and license status. Match rates average 69% against the full database.

Full NameNPI NumberSubspecialtyNPI Taxonomy CodeEmail AddressPractice AddressCity / State / ZIPPhone (where available)Practice SettingLicense StateCell Phone (where available)Home AddressPersonal Email (where available)

Compliance

The SparkDBi infectious disease email list contains no patient data. All records are professional contact information for licensed infectious disease providers. The database is HIPAA-aligned, CAN-SPAM compliant, and CCPA-aware. Business Associate Agreements are available on request.


Frequently Asked Questions


Related HCP Email Lists and Services